Company intelligence / Profile preview

Emboline

Santa Cruz, California, United Statesemboline.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Emboline is developing the Emboliner®, a next-generation embolic protection catheter designed to provide full brain and body protection by capturing and removing emboli generated during TAVR and other high-risk cardiovascular procedures. The device is currently being evaluated in the pivotal "Protect the Head to Head" IDE trial comparing it to an existing control device. Early feasibility studies have shown that the Emboliner captures significantly more clinically relevant debris than partial-protection devices, suggesting potential for improved patient outcomes by reducing stroke risk

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Emboline.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Emboline.

Explore the full profile